Identification of hepatitis C virus genotype 3 by a commercial assay challenged by natural polymorphisms detected in Spain from patients with diverse origins

Journal of Clinical Virology

Volumn 78, Issue , 2016, Pages 14-19

  Saludes, Verónica ^a,b   Quer, Josep ^c,d,e   Gregori, Josep ^c,d,f   Bascuñana, Elisabet ^a   García Cehic, Damir ^c,d   Esteban, Juan Ignacio ^c,d,e   Ausina, Vicente ^a,e,g   Martró, Elisa ^a,b  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^f Roche Diagnostics SL   (Spain)

^g Centro de Investigación Biomédica en Red de Cáncer CIBERONC University of Barcelona   (Spain)

Author keywords

Genotype 3; Genotyping; HCV; Indeterminate; UDPS

Indexed keywords

5' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; ASSAY; BINDING SITE; CLINICAL ARTICLE; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HEPATITIS C VIRUS GENOTYPE 3; HUMAN; LIVER DISEASE; MALE; MIXED INFECTION; PHYLOGENY; PRIORITY JOURNAL; PYROSEQUENCING; SPAIN; VIRUS IDENTIFICATION; VIRUS LOAD; CLASSIFICATION; CLUSTER ANALYSIS; GENETIC VARIATION; GENETICS; HEPACIVIRUS; HEPATITIS C; HIGH THROUGHPUT SEQUENCING; ISOLATION AND PURIFICATION; MIDDLE AGED; VIROLOGY; YOUNG ADULT;

5' UNTRANSLATED REGION;

5' UNTRANSLATED REGIONS; ADULT; AGED; CLUSTER ANALYSIS; FEMALE; GENETIC VARIATION; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MIDDLE AGED; PHYLOGENY; SPAIN; YOUNG ADULT;

EID: 84959328122     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2016.02.024     Document Type: Article

References (21)

1. Smith D.B., Bukh J., Kuiken C., Muerhoff A.S., Rice C.M., Stapleton J.T., Simmonds P. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology 2014, 59:318-327. 10.1002/hep.26744.
2. Dore G.J., Feld J.J. Hepatitis C virus therapeutic development: in pursuit of perfectovir. Clin. Infect. Dis. 2015, 60:1829-1836. 10.1093/cid/civ197.
3. European Association for the Study of the Liver, 2014 EASL recommendations on treatment of hepatitis C. J. Hepatol. 2014, 61:373--395. 10.1016/j.jhep.2014.05.001.
4. Gower E., Estes C., Blach S., Razavi-Shearer K., Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J. Hepatol. 2014, 61:S45--S57. 10.1016/j.jhep.2014.07.027.
5. Messina J.P., Humphreys I., Flaxman A., Brown A., Cooke G.S., Pybus O.G., Barnes E. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 2015, 61:77-87. 10.1002/hep.27259.
6. Kanwal F., Kramer J.R., Ilyas J., Duan Z., El-Serag H.B. HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV. Hepatology 2014, 60:98-105. 10.1002/hep.27095.
7. Ampuero J., Romero-Gómez M., Reddy K.R. Review article: HCV genotype 3-the new treatment challenge. Aliment. Pharmacol. Ther. 2014, 39:686-698.
8. Buti M., Llaneras J., Riveiro-Barciela M., Esteban R. Therapy for hepatitis C genotype 3: moving forward. J. Viral. Hepat. 2015, 22:683-690. 10.1111/jvh.12419.
9. González V., Gomes-Fernandes M., Bascuñana E., Casanovas S., Saludes V., Jordana-Lluch E., Matas L., Ausina V., Martró E. Accuracy of a commercially available assay for HCV genotyping and subtyping in the clinical practice. J. Clin. Virol. 2013, 58:249-253. 10.1016/j.jcv.2013.05.005.
10. Martró E., García-Sierra N., González V., Saludes V., Matas L., Ausina V. Evaluation of an automated nucleic acid extractor for hepatitis C virus load quantification. J. Clin. Microbiol. 2009, 47:811-813. 10.1128/JCM.02181-08.
11. Martró E., González V., Buckton A.J., Saludes V., Fernández G., Matas L., Planas R., Ausina V. Evaluation of a new assay in comparison with reverse hybridization and sequencing methods for hepatitis C virus genotyping targeting both 5' noncoding and nonstructural 5b genomic regions. J. Clin. Microbiol. 2008, 46:192-197.
12. Staden R., Beal K.F., Bonfield J.K. The Staden package, 1998. Methods Mol. Biol. 2000, 132:115-130.
13. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 2011, 28:2731-2739. 10.1093/molbev/msr121.
14. Darriba D., Taboada G.L., Doallo R., Posada D. jModelTest 2: more models, new heuristics and parallel computing. Nat. Methods 2012, 9:772. 10.1038/nmeth.2109.
15. Guindon S., Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst. Biol. 2003, 52:696-704.
16. Quer J., Gregori J., Rodríguez-Frias F., Buti M., Madejon A., Perez-Del-Pulgar S., Garcia-Cehic D., Casillas R., Blasi M., Homs M., Tabernero D., Alvarez-Tejado M., Muñoz J.M., Cubero M., Caballero A., delCampo J.A., Domingo E., Belmonte I., Nieto L., Lens S., Muñoz-de-Rueda P., Sanz-Cameno P., Sauleda S., Bes M., Gomez J., Briones C., Perales C., Sheldon J., Castells L., Viladomiu L., Salmeron J., Ruiz-Extremera A., Quiles-Pérez R., Moreno-Otero R., López-Rodríguez R., Allende H., Romero-Gómez M., Guardia J., Esteban R., Garcia-Samaniego J., Forns X., Esteban J.I. High-resolution hepatitis C virus subtyping using NS5B deep sequencing and phylogeny, an alternative to current methods. J. Clin. Microbiol. 2015, 53:219-226. 10.1128/JCM.02093-14.
17. Benedet M., Adachi D., Wong A., Wong S., Pabbaraju K., Tellier R., Tang J.W. The need for a sequencing-based assay to supplement the Abbott m2000 RealTime HCV Genotype II assay: a 1 year analysis. J. Clin. Virol. 2014, 60:301-304. 10.1016/j.jcv.2014.04.005.
18. Mallory M.A., Lucic D.X., Sears M.T., Cloherty G.A., Hillyard D.R. Evaluation of the Abbott realtime HCV genotype II RUO (GT II) assay with reference to 5'UTR, core and NS5B sequencing. J. Clin. Virol. 2014, 60:22-26. 10.1016/j.jcv.2014.02.006.
19. American Association for the Study of Liver Diseases Recommendations for Testing, Managing, and Treating Hepatitis C 2015, (accessed 07.09.15). http://www.hcvguidelines.org.
20. Amjesh R., Nair A.S., Sugunan V.S. Diversity of hepatitis C virus in Southern India based on 5'UTR sequence. Indian J. Virol. 2012, 23:349-353. 10.1007/s13337-012-0103-2.
21. Hara K., Rivera M.M., Koh C., Sakiani S., Hoofnagle J.H., Heller T. Important factors in reliable determination of hepatitis C virus genotype by use of the 5' untranslated region. J. Clin. Microbiol. 2013, 51:1485-1489. 10.1128/JCM.03344-12.